Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.
Sicklick JK, Kato S, Okamura R, Patel H, Nikanjam M, Fanta PT, Hahn ME, De P, Williams C, Guido J, Solomon BM, McKay RR, Krie A, Boles SG, Ross JS, Lee JJ, Leyland-Jones B, Lippman SM, Kurzrock R.
Sicklick JK, et al. Among authors: nikanjam m.
Genome Med. 2021 Oct 4;13(1):155. doi: 10.1186/s13073-021-00969-w.
Genome Med. 2021.
PMID: 34607609
Free PMC article.